LPL Financial
CYTH

LPL Financial’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

LPL Financial’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,080
Closed -$14.3K – 4604
2022
Q4 		$14.3K Hold
10,080
– – ﹤0.01% 4392
2022
Q3 		$19K Buy
+10,080
New +$21.1K ﹤0.01% 4338

Other funds holding CYTH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SSG
Summit Securities Group New York $1.05B AUM 36.17% 1-Year Est. Return

LPL Financial's CYTH Position: Q1 2023 in Review

LPL Financial sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2023, closing a stake of 10,080 shares — an estimated $14.3K sold.

LPL Financial first reported a position in CYTH in Q3 2022 and held it in 2 quarters. The position peaked at $19K in Q3 2022. 16 funds tracked by Wall St. Rank hold CYTH as of Q1 2023.

  • LPL Financial reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 10,080 Cyclo Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $14.3K.
  • LPL Financial first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • LPL Financial's Cyclo Therapeutics, Inc. Common Stock position peaked at $19K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.